An interventional study of The study is to evaluate the use of the Virtuoso Endoscopy System to perform safe and effective bladder lesion excisions. in Bladder Neoplasm, sponsored by Virtuoso Surgical, Inc.. Enrolling by invitation at 1 site in Hong Kong. Open to participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2026-06-29.
Sponsored by Virtuoso Surgical, Inc. · Not applicable, Interventional, and Diagnostic
A robotic assisted surgery for bladder lesion excision.
This is a single-center, non-randomized study to evaluate the use of the Virtuoso Endoscopy System (VES) to perform safe and effective bladder lesion excisions.
1,616 studies on the registry are indexed under Urinary Bladder Neoplasms; 421 are open to participants now.
This study's planned enrollment of 30 is below the median of 60 across 1,163 interventional studies indexed under Urinary Bladder Neoplasms.
Browse Urinary Bladder Neoplasms studies →This is the only study on the registry with Virtuoso Surgical, Inc. as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
This study will enroll subjects 22 years and older with bladder lesions that require removal and/or biopsy for diagnosis, who meet all the inclusion criteria and none of the exclusion criteria. The study purpose is to evaluate the use of the Virtuoso Endoscopy System (VES) to perform safe and effective bladder lesion excisions.
Device: The study is to evaluate the use of the Virtuoso Endoscopy System to perform safe and effective bladder lesion excisions.
This study is to evaluate the use of the Virtuoso Endoscopy System (VES), which is a robotic enhanced system, to perform safe and effective bladder lesion excisions.
Detrusor muscle presence in the pathologic specimen after VES procedure
Time frame: Through study completion, an average of 30 days
Adverse events
Time frame: Intraoperative
Adverse events
Time frame: Through study completion, an average of 30 days
Rate of conversion to standard cTURBT equipment
Time frame: Intraoperative
Rate of en bloc excision with VES
Time frame: Intraoperative
Complications (Clavien-Dindo)
Time frame: Intraoperative
Significant bladder perforation requiring intervention
Time frame: Intraoperative
Urethral injury
Time frame: Intraoperative
Transfusion rate
Time frame: Intraoperative
Estimated blood loss
Time frame: Intraoperative
Rate of patients where the obturator nerve complex was observed
Time frame: Intraoperative
Mortality
Time frame: Intraoperative
VES surgery procedural time
Time frame: Intraoperative
Presence of clear, evaluable margins in excised specimen
Time frame: Through study completion, an average of 30 days
Time of catheterization
Time frame: Through study completion, an average of 30 days
Time of hospital stay
Time frame: Through study completion, an average of 30 days
Complications (Clavien-Dindo)
Time frame: Through study completion, an average of 30 days
Significant bladder perforation requiring intervention
Time frame: Through study completion, an average of 30 days
Urethral injury
Time frame: Through study completion, an average of 30 days
30-day reoperation rate
Time frame: Through study completion, an average of 30 days
30-day hospital readmission rate
Time frame: Through study completion, an average of 30 days
30-day mortality
Time frame: Through study completion, an average of 30 days
Plan to share: Undecided
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.